Skip to main content
Caplight Logo









Chunyuan Capital

Chunyuan Capital

Overview

Chunyuan Capital is a healthcare-focused investment firm that provides strategic capital to high-growth companies in the medical and life sciences sectors.

Year Founded

2014

Portfolio Companies

1

Investments

Chunyuan Capital investments
CompanyDateStageLead
Shanghai Ligatech Bioscience Co., Ltd.Nov 2020Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Chunyuan Capital based?

Chunyuan Capital is headquartered in Shanghai, China.

When was Chunyuan Capital founded?

Chunyuan Capital was founded in 2014.

How many portfolio companies does Chunyuan Capital have?

Chunyuan Capital has 1 portfolio company in Caplight's dataset.

What are some companies in Chunyuan Capital's portfolio?

Portfolio companies visible on Caplight include Shanghai Ligatech Bioscience Co., Ltd..

What was Chunyuan Capital's most recent investment shown here?

Chunyuan Capital's most recent investment in this portfolio sample was in Shanghai Ligatech Bioscience Co., Ltd. in 2020.

What sectors does Chunyuan Capital focus on?

Chunyuan Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does Chunyuan Capital focus on?

Chunyuan Capital typically invests at the Mid stage.

Firmographic Details

HeadquartersShanghai
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?